- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06529107
Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy
July 25, 2024 updated by: Lu Xing, West China Second University Hospital
In this study, the investigators summarize the existing best evidence of intermittent catheterization in patients after radical cervical cancer surgery from the perspective of clinical translation of evidence through systematic search, evaluation and evidence integration, construct a nursing protocol of intermittent catheterization for patients after radical cervical cancer surgery based on the best evidence combined with the clinical context, and explore the clinical application effect of the above nursing protocol.
It will provide a reference basis for the development of the standardization and management of intermittent catheterization for postoperative patients with cervical cancer in China, as well as the development of guidelines for intermittent catheterization after radical cervical cancer surgery.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lu Xing
- Phone Number: +8619827473462
- Email: xinglu_0707@163.com
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China
- Recruiting
- West China Second University Hospital, Sichuan University
-
Contact:
- Lu Xing
- Phone Number: +8619827473462
- Email: xinglu_0707@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≧ 18 years old
- Radical cervical cancer surgery and intermittent catheterization were performed at the Institute's hospital
- Patients or their family members can operate a smartphone
- No cognitive or psychiatric disorders, and can communicate effectively
Exclusion Criteria:
- People with serious heart, brain, lung and other important organ diseases
- People with water, electrolyte, acid-base balance disorders at the beginning of intermittent catheterization
- People with previous serious renal diseases, bladder and urethra surgery
- People with urinary tract infections
- People who did not complete all interventions or data collection
- People who voluntarily withdrew from the study or died during the study period;
- Refuse to participate in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: A best evidence-based protocol for intermittent catheterization
|
A best evidence-based protocol for intermittent catheterization after radical cervical cancer surgery
|
|
No Intervention: Routine intermittent catheterization care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of urinary complications
Time Frame: Within 2 months of discharge
|
the occurrence of urologic complications within 2 months after discharge of the patients from the hospital for follow-up, which in this study included urinary tract infections, urethral injuries, bladder stones, hydronephrosis
|
Within 2 months of discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intermittent Catheterization Compliance Scale
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
A questionnaire was used to investigate patients' adherence to carrying out intermittent catheterization before the intervention, immediately after the intervention, and 1 month after discharge from the hospital.
Higher scores indicate better adherence.
|
Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
|
12-Item Short Form Survey
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
A questionnaire was used to investigate patients' quality of life before and immediately after the intervention and 1 month after discharge.
Higher scores indicate better quality of life.
|
Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
|
Self-Rating Anxiety Scale
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
A questionnaire was used to investigate patients' anxiety before and immediately after the intervention and 1 month after discharge from the hospital.
Higher scores indicate greater anxiety.
|
Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
|
Intermittent Catheterization Confidence Scale
Time Frame: Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
A questionnaire was used to investigate patients' self-efficacy before and immediately after the intervention and 1 month after discharge from the hospital.
Higher scores indicate greater confidence.
|
Pre-intervention, immediately post-intervention, and 1 month post-discharge
|
|
Utilization of health services
Time Frame: Within 2 months of discharge
|
Follow-up to record the number of unplanned readmissions, outpatient visits, and emergency room visits within 2 months of discharge and to evaluate the patient's health service utilization
|
Within 2 months of discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2024
Primary Completion (Estimated)
December 10, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
July 20, 2024
First Submitted That Met QC Criteria
July 25, 2024
First Posted (Actual)
July 31, 2024
Study Record Updates
Last Update Posted (Actual)
July 31, 2024
Last Update Submitted That Met QC Criteria
July 25, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2023203
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intermittent Catheterization
-
Coloplast A/SIQVIA Pty LtdNot yet recruitingIntermittent Catheterization
-
BBraun Medical SASCompletedIntermittent Urethral CatheterizationFrance
-
Wellspect HealthCareCompletedIntermittent Urethral CatheterizationAustralia, United States
-
Wellspect HealthCareCompletedIntermittent CatheterizationBelgium, United Kingdom, France, Netherlands, Norway, Switzerland
-
Gérard AmarencoCompletedIntermittent Urethral CatheterizationFrance
-
Wellspect HealthCareWellspect HealthCareCompletedFemale Intermittent Urethral CatheterizationSpain, Sweden
-
Mersin UniversityNot yet recruitingClean Intermittent CatheterizationTurkey (Türkiye)
-
Coloplast A/SCompletedIntermittent Urethral CatheterizationDenmark
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Wellspect HealthCareCompletedCatheterization (Clean, Intermittent Urinary Catheterization)Sweden
Clinical Trials on intermittent catheterization protocol based on the best evidence
-
Universidad Rey Juan CarlosCompletedUltrasound-Guided Percutaneous Electrical Nerve StimulationSpain
-
Istanbul University - CerrahpasaActive, not recruitingMetacognition | Flipped Education Model | Web Based Education | Self Directed LearningTurkey
-
Istanbul University - CerrahpasaCompletedEvidence Based Practice | Flipped Education ModelTurkey
-
Jenny GentizonManuel Simon; Julien Elowe; Luca ScuderiNot yet recruitingBorderline Personality DisorderSwitzerland
-
Tulane UniversityNational Institutes of Health (NIH)Active, not recruitingChurch-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health (CHERISH)Cardiovascular Diseases | Hypertension | Diabetes | HypercholesterolemiaUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Yale University; AstraZenecaRecruitingHeart Failure With Reduced Ejection FractionNetherlands
-
Yale UniversityAstraZenecaCompletedHeart Failure With Reduced Ejection FractionUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedExposure to Sexually Transmissible Disorder (Event)United States
-
Yale UniversityAstraZenecaCompletedHeart FailureUnited States
-
Eye & ENT Hospital of Fudan UniversityCompleted